Shares of Verici Dx plc (LON:VRCI – Get Free Report) were down 10.3% during mid-day trading on Friday . The stock traded as low as GBX 5.16 ($0.06) and last traded at GBX 5.16 ($0.06). Approximately 1,575,868 shares changed hands during trading, an increase of 20% from the average daily volume of 1,313,229 shares. The stock had previously closed at GBX 5.75 ($0.07).
Verici Dx Stock Performance
The company has a debt-to-equity ratio of 4.65, a current ratio of 4.54 and a quick ratio of 8.49. The stock has a market cap of £12.13 million, a P/E ratio of -250.00 and a beta of 1.59. The company has a 50 day simple moving average of GBX 3.29 and a 200-day simple moving average of GBX 5.26.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Further Reading
- Five stocks we like better than Verici Dx
- Differences Between Momentum Investing and Long Term Investing
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- The How and Why of Investing in Gold Stocks
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
